These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21482037)

  • 21. Management of retroperitoneal lymph nodes in advanced ovarian cancer.
    Hacker NF; Valmadre S; Robertson G
    Int J Gynecol Cancer; 2008; 18 Suppl 1():7-10. PubMed ID: 18336392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The surgical treatment of ovarian cancer].
    Burghardt E; Lahousen M; Stettner H
    Geburtshilfe Frauenheilkd; 1990 Sep; 50(9):670-7. PubMed ID: 2272432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The role of pelvic lymphadenectomy in the therapy of prostate and bladder cancer].
    Heidenreich A; Ohlmann CH
    Aktuelle Urol; 2005 Jun; 36(3):219-29. PubMed ID: 16001337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymph node metastasis in stage I epithelial ovarian cancer.
    Suzuki M; Ohwada M; Yamada T; Kohno T; Sekiguchi I; Sato I
    Gynecol Oncol; 2000 Nov; 79(2):305-8. PubMed ID: 11063662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Lymphadenectomy in the treatment of malignant ovarian germ cell tumor].
    Jin Y; Pan LY; Huang HF; Shen K; Wu M; Yang JX; Lang JH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Dec; 27(6):743-8. PubMed ID: 16447650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controversies in the management of ovarian cancer--pros and cons for lymph node dissection in ovarian cancer.
    Camara O; Sehouli J
    Anticancer Res; 2009 Jul; 29(7):2837-43. PubMed ID: 19596971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of retroperitoneal lymphadenectomy on prognosis of patients with epithelial ovarian cancer.
    Wang Z; Xiong Z; Wang S
    Chin Med J (Engl); 2003 Apr; 116(4):588-92. PubMed ID: 12875728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in treatment of epithelial ovarian cancer.
    Kikkawa F; Nawa A; Ino K; Shibata K; Kajiyama H; Nomura S
    Nagoya J Med Sci; 2006 Jan; 68(1-2):19-26. PubMed ID: 16579172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical significance of occult macroscopically positive retroperitoneal nodes in patients with epithelial ovarian cancer.
    Eisenkop SM; Spirtos NM
    Gynecol Oncol; 2001 Jul; 82(1):143-9. PubMed ID: 11426976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Lumbo-aortic lymphadenectomy in ovarian cancers].
    Bonnier P; Piana L
    Ann Chir; 1991; 45(6):450-3; discussion 454-5. PubMed ID: 1929159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systematic para-aortic and pelvic lymphadenectomy in early stage epithelial ovarian cancer: a prospective study.
    Ditto A; Martinelli F; Reato C; Kusamura S; Solima E; Fontanelli R; Haeusler E; Raspagliesi F
    Ann Surg Oncol; 2012 Nov; 19(12):3849-55. PubMed ID: 22707110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphatic spread among women with primary peritoneal carcinoma.
    Eltabbakh GH; Mount SL
    J Surg Oncol; 2002 Nov; 81(3):126-31. PubMed ID: 12407724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of lymphadenectomy in ovarian cancer.
    Panici PB; Angioli R
    Best Pract Res Clin Obstet Gynaecol; 2002 Aug; 16(4):529-51. PubMed ID: 12413933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic pelvic and aortic lymphadenectomy in intermediate and high-risk endometrial cancer: lymph-node mapping and identification of predictive factors for lymph-node status.
    Fotopoulou C; Savvatis K; Kraetschell R; Schefold JC; Lichtenegger W; Sehouli J
    Eur J Obstet Gynecol Reprod Biol; 2010 Apr; 149(2):199-203. PubMed ID: 20096987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The role of lymph node dysection in early and advanced stages of ovarian cancer].
    Ismail E; Kornovski Y
    Akush Ginekol (Sofiia); 2014; 53(8):17-20. PubMed ID: 25672085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prospective randomized multicenter trial for lymphadenectomy in early-stage ovarian cancer: LOVE study.
    Deng T; Liu K; Chen L; Chen X; Li HW; Guo H; Zhang H; Xiang L; Feng X; Wang X; Ngan HY; Zhao J; Zou D; Liu Q; Liu J
    J Gynecol Oncol; 2023 May; 34(3):e52. PubMed ID: 37116952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A rational selection of retroperitoneal lymphadenectomy for advanced epithelial ovarian cancer].
    Wang W; Sun R; Ma L
    Zhonghua Fu Chan Ke Za Zhi; 1999 Feb; 34(2):108-9. PubMed ID: 11263195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maximum effort in the management of ovarian cancer, including pelvic and para-aortic lymphadenectomy.
    Allen DG; Planner RS; Grant PT
    Aust N Z J Obstet Gynaecol; 1992 Feb; 32(1):50-3. PubMed ID: 1586336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of pelvic and aortic lymphadenectomy at second look surgery in apparent early stage ovarian cancer after inadequate surgical staging followed by adjuvant chemotherapy.
    Signorelli M; Fruscio R; Ceppi L; Dell'anna T; Vitobello D; Chiappa V; Siesto G; Milani R; Landoni F; Mangioni C
    Gynecol Oncol; 2014 Feb; 132(2):312-5. PubMed ID: 24423881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [An analysis of pelvic and para-aortic lymph node metastasis in ovarian carcinoma by systematic retroperitoneal lymph node dissection].
    Tsumura N; Sakuragi N; Hareyama H; Nomura E; Ohkouchi T; Yamamoto R; Takeda N; Nishiya M; Hirahatake K; Fujino T; Okubo H; Satoh C; Makinoda S; Kawaguchi I; Fujimoto S
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Jul; 48(7):508-14. PubMed ID: 8754392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.